Alterity Therapeutics Limited
ATHENASDAQHealthcare● Active
$4.35
+$0.44(+11.11%)
Market Cap$39432154
P/E Ratio—
52W High$7
52W Low$2.66
Alterity Therapeutics Limited (ATHE) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ATHE · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $5.44M | $4.02M | $3.92M | $5.12M | $4.34M |
| Cost of Revenue | $0.13M | $0.21M | $0.29M | $0.36M | $0.36M |
| Gross Profit | $5.31M | $3.80M | $3.63M | $4.76M | $3.98M |
| Gross Margin %(computed) | 97.66% | 94.67% | 92.72% | 92.88% | 91.70% |
| Operating Expenses | |||||
| R&D Expenses | $14.40M | $18.64M | $13.20M | $14.75M | $12.28M |
| G&A Expenses | $5.48M | $4.77M | $4.99M | $5.43M | $6.85M |
| Total Operating Expenses | $19.89M | $23.41M | $18.24M | $20.26M | $19.16M |
| Operating Income | ($14.57M) | ($19.60M) | ($14.64M) | ($15.50M) | ($15.18M) |
| Operating Margin %(computed) | -267.96% | -487.69% | -373.72% | -302.56% | -349.77% |
| Interest Income | $0.45M | $0.27M | $0.02M | $0.00M | $0.02M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($12.08M) | ($19.08M) | ($13.70M) | ($12.78M) | ($15.31M) |
| Income Tax Expense | $0.07M | $0.05M | $0.10M | $0.07M | $0.00M |
| Net Income | ($12.15M) | ($19.12M) | ($13.81M) | ($12.85M) | ($15.31M) |
| Net Margin %(computed) | -223.35% | -475.79% | -352.54% | -250.75% | -352.78% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.14 | $-3.12 | $-3.42 | $-3.18 | $-5.40 |
| Wtd Avg Shares | 10.66M | 6.08M | 4.05M | 4.01M | 2.83M |
| EBITDA | ($14.63M) | ($19.57M) | ($14.60M) | ($17.39M) | ($15.16M) |
| EBITDA Margin %(computed) | -269.05% | -486.94% | -372.75% | -339.46% | -349.34% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · AUD · M
Explore more Alterity Therapeutics Limited data
About Alterity Therapeutics Limited (ATHE) Income Statement
Alterity Therapeutics Limited (ATHE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ATHE reported revenue of $0.01B, gross profit of $0.01B (gross margin 97.66%), and net income of ($0.01B) — a net profit margin of -223.35%.
Frequently asked questions
ATHE · 4 questionsAlterity Therapeutics Limited (ATHE) reported revenue of $0.01B for 2025, up 35.3% year-over-year.
ATHE revenueATHE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09